Lapinig, Cherryl Mae O.
HRN: 18-87-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2025
CEFTRIAXONE 1G (VIAL)
12/01/2025
12/08/2025
IVT
2GMS
OD
PELVIC LAPAROTOMY
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes